Erik Walum

3.5k total citations
114 papers, 2.5k citations indexed

About

Erik Walum is a scholar working on Molecular Biology, Small Animals and Cellular and Molecular Neuroscience. According to data from OpenAlex, Erik Walum has authored 114 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 27 papers in Small Animals and 26 papers in Cellular and Molecular Neuroscience. Recurrent topics in Erik Walum's work include Animal testing and alternatives (26 papers), Neuroscience and Neuropharmacology Research (23 papers) and Carcinogens and Genotoxicity Assessment (11 papers). Erik Walum is often cited by papers focused on Animal testing and alternatives (26 papers), Neuroscience and Neuropharmacology Research (23 papers) and Carcinogens and Genotoxicity Assessment (11 papers). Erik Walum collaborates with scholars based in Sweden, Netherlands and Italy. Erik Walum's co-authors include Anders Peterson, Å. Edström, Björn Ekwall, Martin Kanje, Lennart Romert, Anna Forsby, Cecilia Clemedson, Sven Hellberg, K Stenberg and Jonas Ekblom and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Erik Walum

112 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik Walum Sweden 27 766 513 429 355 322 114 2.5k
Jean‐Pierre Valentin United Kingdom 39 1.8k 2.4× 430 0.8× 672 1.6× 115 0.3× 270 0.8× 198 4.2k
Kyle L. Kolaja United States 30 2.0k 2.6× 96 0.2× 673 1.6× 325 0.9× 163 0.5× 70 3.6k
G. Zbinden Switzerland 21 492 0.6× 189 0.4× 114 0.3× 127 0.4× 138 0.4× 148 1.7k
Xavier Ponsoda Spain 29 739 1.0× 107 0.2× 173 0.4× 139 0.4× 110 0.3× 65 2.2k
Ryuji Kato Japan 29 1.4k 1.8× 27 0.1× 400 0.9× 118 0.3× 339 1.1× 127 3.5k
Ryohei Hasegawa Japan 35 1.6k 2.1× 65 0.1× 93 0.2× 469 1.3× 96 0.3× 201 4.3k
Toyoko Hiroi Japan 32 825 1.1× 24 0.0× 292 0.7× 186 0.5× 208 0.6× 65 2.7k
Masamichi Hirose Japan 27 1.1k 1.5× 30 0.1× 163 0.4× 106 0.3× 189 0.6× 129 2.9k
Gregory Moore Sweden 19 777 1.0× 41 0.1× 212 0.5× 116 0.3× 163 0.5× 40 1.8k
Chung‐Ren Jan Taiwan 26 1.4k 1.8× 17 0.0× 408 1.0× 135 0.4× 162 0.5× 188 2.6k

Countries citing papers authored by Erik Walum

Since Specialization
Citations

This map shows the geographic impact of Erik Walum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Walum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Walum more than expected).

Fields of papers citing papers by Erik Walum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Walum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Walum. The network helps show where Erik Walum may publish in the future.

Co-authorship network of co-authors of Erik Walum

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Walum. A scholar is included among the top collaborators of Erik Walum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Walum. Erik Walum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xuan, et al.. (2018). The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro. PLoS ONE. 13(9). e0204271–e0204271. 57 indexed citations
2.
Anvari, Enayat, Pernilla Wikström, Erik Walum, & Nils Welsh. (2015). The novel NADPH oxidase 4 inhibitor GLX351322 counteracts glucose intolerance in high-fat diet-treated C57BL/6 mice. Free Radical Research. 49(11). 1308–1318. 70 indexed citations
3.
Kolman, Ada & Erik Walum. (2010). Björn Ekwall, an outstanding Swedish cell toxicologist. Toxicology in Vitro. 24(8). 2060–2062. 3 indexed citations
4.
Högberg, Helena T., et al.. (2006). Temperature Dependence of O2 Consumption; Opposite Effects of Leptin and Etomoxir on Respiratory Quotient in Mice. Obesity. 14(4). 673–682. 33 indexed citations
5.
Walum, Erik, et al.. (2003). Acrylamide-induced effects on general and neurospecific cellular functions during exposure and recovery. Cell Biology and Toxicology. 19(1). 43–51. 48 indexed citations
6.
Walum, Erik, et al.. (2000). Expression and intracellular localization of leptin receptor long isoform-GFP chimera. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1499(1-2). 130–138. 25 indexed citations
7.
Curren, Rodger, Leon H. Bruner, Alan M. Goldberg, & Erik Walum. (1998). 13th Meeting of the Scientific Group on Methodologies for the Safety Evaluation of Chemicals (SGOMSEC): validation and acute toxicity testing.. Environmental Health Perspectives. 106(suppl 2). 419–425. 8 indexed citations
8.
Walum, Erik & Anna Forsby. (1995). Measurement of Cell Membrane Toxicity by Means of 2-Deoxy-D-Glucose. Humana Press eBooks. 43. 129–135. 1 indexed citations
9.
Blaauboer, Bas J., Michael Balls, Vera Bianchi, et al.. (1994). The ECITTS integrated toxicity testing scheme: The application of in vitro test systems to the hazard assessment of chemicals. Toxicology in Vitro. 8(4). 845–846. 15 indexed citations
10.
Romert, Lennart, et al.. (1994). Glutathione content, glutathione transferase activity and lipid peroxidation in acrylamide-treated neuroblastoma N1E 115 cells. Toxicology in Vitro. 8(2). 263–267. 26 indexed citations
11.
Sundwall, A., Bo Andersson, Michael Balls, et al.. (1994). Workshop: Immunotoxicology and in vitro possibilities. Toxicology in Vitro. 8(5). 1067–1074. 4 indexed citations
12.
Walum, Erik, et al.. (1993). Cellular methods for identification of neurotoxic chemicals and estimation of neurotoxicological risk. Toxicology in Vitro. 7(4). 321–326. 21 indexed citations
13.
Ekblom, Jonas, et al.. (1993). Monoamine oxidase‐B in astrocytes. Glia. 8(2). 122–132. 107 indexed citations
14.
Walum, Erik, Michael Balls, Vera Bianchi, et al.. (1992). ECITTS: An Integrated Approach to the Application of In Vitro Test Systems to the Hazard Assessment of Chemicals,. Alternatives to Laboratory Animals. 20(3). 406–428. 27 indexed citations
15.
Ekwall, Björn, M.J. Gómez-Lechón, Sven Hellberg, et al.. (1990). Preliminary results from the Scandinavian multicentre evaluation of in vitro cytotoxicity (MEIC). Toxicology in Vitro. 4(4-5). 688–691. 12 indexed citations
16.
Clemedson, Cecilia, Marc Schmid, & Erik Walum. (1989). Effects of carbon tetrachloride on embryonic development studied in the post-implantation rat embryo culture system and in chick embryos in ovo. Toxicology in Vitro. 3(4). 271–275. 9 indexed citations
17.
Clemedson, Cecilia, Anders Peterson, & Erik Walum. (1989). A Combined in Ovo‐in Vitro System for Studies of Volatile Compounds on Brain Development: Differential Effects of Carbon Tetrachloride on Neurones and Astrocytes. Pharmacology & Toxicology. 64(1). 94–99. 10 indexed citations
18.
Ekwall, Björn, et al.. (1989). MEIC—A new international multicenter project to evaluate the relevance to human toxicity of in vitro cytotoxicity tests. Cell Biology and Toxicology. 5(3). 331–347. 147 indexed citations
19.
Walum, Erik. (1981). Uptake and release of choline in cultures of human glioma cells. Cellular and Molecular Neurobiology. 1(4). 389–399. 6 indexed citations
20.
Kanje, Martin, Erik Walum, & Å. Edström. (1979). Effects of dibutyryl cyclic AMP and cytochalasin B on cultured human glioma cells.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 93(3). 487–96. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Pierre Valentin Breakdown of academic impact, for papers by Kyle L. Kolaja Breakdown of academic impact, for papers by G. Zbinden Breakdown of academic impact, for papers by Xavier Ponsoda Breakdown of academic impact, for papers by Ryuji Kato Breakdown of academic impact, for papers by Ryohei Hasegawa Breakdown of academic impact, for papers by Toyoko Hiroi Breakdown of academic impact, for papers by Masamichi Hirose Breakdown of academic impact, for papers by Gregory Moore Breakdown of academic impact, for papers by Chung‐Ren Jan
Rankless by CCL
2026